
The average BioMarin Pharmaceutical Inc. Sr Financial Analyst in Boulder earns an estimated $91,989 annually, which includes an estimated base salary of $73,739 with a $18,250 bonus. BioMarin Pharmaceutical Inc. Sr Financial Analyst compensation is $4,581 more than the US average for a Sr Financial Analyst. Sr Financial Analyst salaries at BioMarin Pharmaceutical Inc. in Boulder can range from $75,000 - $105,000.
In Boulder, The Finance Department at BioMarin Pharmaceutical Inc. earns $12,109 more on average than the Operations Department.
Last updated 2 months ago.
In Boulder, Sr Financial Analysts earn $3,884 more than Business Analysts, and $360 less than Financial Analysts.
In Boulder, The Finance Department averages $12,109 more than the Operations Department, and $10,128 less than the Business Development Department
The average female Sr Financial Analyst at companies similar size to BioMarin Pharmaceutical Inc. reported making $89,790, while the average male Sr Financial Analyst at similar sized companies reported making $94,632.
The average Asian or Pacific Islander Sr Financial Analyst at companies similar size to BioMarin Pharmaceutical Inc. reported making $97,825, while the average African American/Black Sr Financial Analyst at similar sized companies reported making $68,750.
The majority of Sr Financial Analysts at BioMarin Pharmaceutical Inc. believe they're compensated fairly. 100% of Sr Financial Analysts at BioMarin Pharmaceutical Inc. say they receive annual bonuses, and the vast majority (78%) are satisfied with their benefits. See more compensation ratings at BioMarin Pharmaceutical Inc.